Zhejiang Sanhua Intelligent Controls(02050): Li Zhimi has been appointed as Co-Secretary of the Company.
Sanhua Smart Control (02050) announced that Mr. Hu Kaicheng (Mr. Hu) has resigned as the joint company secretary of the company due to work arrangements, and it will be effective from April 22, 2026.
Zhejiang Sanhua Intelligent Controls (02050) announced that due to work arrangements, Mr. Hu Kaicheng (Mr. Hu) has resigned as the Joint Company Secretary of the company, effective from April 22, 2026.
The Board further announced that Ms. He Yongya (Ms. He) has resigned as (i) the Joint Company Secretary of the company; (ii) the authorized representative of the company under Rule 3.05 of the Listing Rules of The Stock Exchange of Hong Kong Limited (SEHK); and (iii) the authorized representative for receiving legal process documents and notices in Hong Kong under Rule 19A.13 (2) of the Listing Rules and section 16 of the Companies Ordinance (Chapter 622) of Hong Kong, effective from April 22, 2026, in order to focus on her professional responsibilities and personal matters, as well as to pay more attention to customer business and strategic management.
Ms. Li Zhimi and Ms. Guo Enting have been appointed as the Joint Company Secretaries of the company, effective from April 22, 2026. Ms. Guo has also been appointed as the authorized representative and the authorized representative for receiving legal process documents and notices, effective from April 22, 2026.
Related Articles

US Stock Market Move | Q1 performance exceeds expectations Intuitive Surgical, Inc. (ISRG.US) rose more than 8% in early trading.

JIANGSU EXPRESS (00177) plans to increase capital by 128 million yuan to Danjin Company.

SIMCERE PHARMA (02096): has voluntarily withdrawn the NDA for Ludechig Bai monoclonal antibody and is expected to resubmit the NDA later this month.
US Stock Market Move | Q1 performance exceeds expectations Intuitive Surgical, Inc. (ISRG.US) rose more than 8% in early trading.

JIANGSU EXPRESS (00177) plans to increase capital by 128 million yuan to Danjin Company.

SIMCERE PHARMA (02096): has voluntarily withdrawn the NDA for Ludechig Bai monoclonal antibody and is expected to resubmit the NDA later this month.

RECOMMEND

DeepSeek’s $10 Billion Valuation Financing Rumor And Four Layers Of Logical Judgment
21/04/2026

48 Hours Witness AI’s New Battlefield: Alibaba Joins, Tencent Open Sources, Manycore Tech Lists — Has The World Model Reached Its ChatGPT Moment?
21/04/2026

Public Fund Giants Reverse Course With Heavy Hong Kong IPO Cornerstone Allocations Exceeding HK$2.2 Billion Year‑To‑Date
21/04/2026


